Biomerica Profit Margin

The latest profit margin for BMRA is -96.49% as of February 2026. That compares with -85.42% in the prior-year period — down 13.0% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Biomerica's historical trend and sector peers before judging valuation or financial health.

Over the past year, BMRA's profit margin moved from -85.42% to -96.49% — a 13.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Biomerica's valuation or profitability profile.

Against Healthcare companies, BMRA currently prints -96.49% for profit margin, while the sector average sits near 13.89%. That is roughly 794.5% below the sector mean. Large gaps often invite a closer look at Biomerica's growth, margins, and balance sheet.

Profit Margin shows how effectively Biomerica converts resources into returns. At -96.49%, BMRA may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -85.42% in the prior-year period — down 13.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BMRA's profit margin (-96.49%), review year-over-year change from -85.42%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.